Skip to content
LFVN

Lifevantage Corp

Lifevantage Corp Q3 FY2026 earnings call

May 6, 2026 · fiscal period ended 2026-03

EPS · actual vs est

$0.12 / $0.16Miss -25.0%

Revenue · actual vs est

$43.7M / $47.8MMiss -8.5%
Ask about this call

Summary

Generated 2026-05-06

Management highlights

Michael Beindorf introduced himself, recognized Steve Fife's retirement. Talked about product portfolio including ProTandem family, TrueScience Liquid Collagen, etc. Mentioned Momentum Academy in Las Vegas, VIP bonus program. Invested in digital capabilities, e-commerce platform upgrade. Announced U.S. patent for Healthy Glow Essentials stack. Appointed Terrence Moorhead as next CEO.

View in transcript ↓

Segment performance

For the third quarter of fiscal 2026, net revenue was $43.7 million, down 25.2% from $58.4 million in the prior year. Americas region revenue decreased 28.9% to $34.3 million, Asia Pacific and Europe region decreased 7.7% to $9.4 million. Gross profit percentage was 79%, non-GAAP adjusted gross profit percentage 79.4%. Commissions and incentive expense as a percentage of revenue was 43.5%. Selling general and administrative expenses were 31.7% of revenue. GAAP operating income was $1.7 million, adjusted non-GAAP operating income $1.8 million. GAAP net income $1.4 million, adjusted non-GAAP net income $1.5 million.

View in transcript ↓

Guidance

Now expect to end fiscal 2026 with revenue, adjusted EBITDA, and adjusted earnings per share close to the lower end of previously issued guidance range. Reflects GLP-1 market competitive dynamics and cost management while investing in strategic growth initiatives.

View in transcript ↓

Q&A highlights

Q: Doug Lane asked about cash from operations, CapEx, share buyback, consultant count, new products.

A: Carl and Kristen responded regarding cash from operations expected similar in Q4, CapEx to be consistent, commitment to share buyback, efforts to address consultant count in Americas and plans for new products including annual convention in October with a science-backed product in the works

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS$0.12$0.16-25.0%
Revenue$43.7M$47.8M-8.5%

Transcript

May 6, 2026

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.